Select a medication above to begin.
Odactra
house dust mite allergen extract
Black Box Warnings .
Severe Hypersensitivity Reaction
life-threatening reactions including anaphylaxis and severe laryngopharyngeal restriction may occur; do not give to patients with severe, unstable or uncontrolled asthma; tx may not be suitable for patients with underlying medical conditions that may decr. ability to survive serious hypersensitivity reactions; observe patients for signs/symptoms of hypersensitivity reaction for at least 30min after 1st dose; prescribe epinephrine and instruct patients or parents/guardians on appropriate use and to seek immediate medical care upon use; allergen immunotherapy may not be suitable for patients potentially unresponsive to epinephrine or inhaled bronchodilators, such as patients taking beta-blockers
Adult Dosing .
Dosage forms: SL TAB: 12 SQ-HDM
allergic rhinitis, house dust mite-induced
- [18-65 yo]
- Dose: 1 tab SL qd
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: SL TAB: 12 SQ-HDM
allergic rhinitis, house dust mite-induced
- [5 yo and older]
- Dose: 1 tab SL qd
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- hypersensitivity reaction history, severe
- sublingual allergen immunotherapy-associated local reaction history, severe
- asthma, severe
- asthma, unstable
- asthma, uncontrolled
- eosinophilic esophagitis history
- oral wound, unhealed
- oral inflammation, unhealed
- caution: allergen immunotherapy use, concurrent
Drug Interactions .
Overview
house dust mite allergen extract
allergen
-
None
No significant interactions known or found for this drug. Caution always advised with multiple medications.
Adverse Reactions .
Serious Reactions
- hypersensitivity reaction
- anaphylaxis
- angioedema
- laryngopharyngeal edema
- eosinophilic esophagitis
Common Reactions
- throat irritation
- pruritus
- pharyngeal edema
- lip swelling
- tongue swelling
- nausea
- tongue pain
- abdominal pain
- oral ulcer
- taste changes
- diarrhea
- vomiting
- oral paresthesia
- oral pain
- stomatitis
- dyspepsia (adult patients)
- chest discomfort (peds patients)
- pharyngeal erythema (adult patients)
Safety/Monitoring .
Monitoring Parameters
signs/symptoms of hypersensitivity reaction for at least 30min after 1st dose
Pregnancy/Lactation .
Pregnancy
Clinical Summary
weigh risk/benefit during pregnancy; no human data available, though risk of fetal harm not expected based on human data with other allergen immunotherapy agents
Lactation
Clinical Summary
weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production
Pharmacology .
Metabolism: for house dust mite allergen extract: unknown; CYP450: unknown
Excretion: for house dust mite allergen extract: unknown; Half-life: unknown
Subclass: Allergen Immunotherapy
Mechanism of Action
for house dust mite allergen extract: exact mechanism of action unknown; alters immune response and promotes tolerance through repeated allergen-specific exposure
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.